Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
about
Rationale for interleukin-6 blockade in systemic lupus erythematosusGas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritisThe role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity.Current and emerging treatment options in the management of lupusKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsLupus nephritis: the evolving role of novel therapeuticsSilica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 MouseTocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.Tumour necrosis factor and other cytokines in murine lupus.Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.Requirements for innate immune pathways in environmentally induced autoimmunity.Novel therapeutic agents in clinical development for systemic lupus erythematosus.B Cell and BAFF dependence of IFN-α-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice.The role of cytokine in the lupus nephritis.Cytokine disturbances in systemic lupus erythematosus.Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN.Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLENovel treatments for systemic lupus erythematosus.Human embryonic stem cell-derived mesenchymal cells preserve kidney function and extend lifespan in NZB/W F1 mouse model of lupus nephritisNuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GNIL-6 Trans-Signaling Drives Murine Crescentic GNCorrection or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantationCytokines in systemic lupus erythematosusMediators of inflammation and their effect on resident renal cells: implications in lupus nephritisThe pathophysiology of hypertension in systemic lupus erythematosus.Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling.Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.Role of TWEAK in lupus nephritis: a bench-to-bedside review.Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown.Thermodynamic analysis of monoclonal antibody binding to duplex DNA.Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion.The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure.Up-regulation of cytokines in glomerulonephritis associated with murine malaria infection.New insights into the role of renal resident cells in the pathogenesis of lupus nephritis.
P2860
Q24564990-E92F6C22-CEC6-4D9C-8287-D919C494D3B2Q24672961-E35506B6-A936-4AAC-8731-A07B1594AF5AQ24805385-D66D19FF-37AC-493B-A257-929CC123F2A7Q26741266-67BF2E2C-68A3-4DA7-9A1E-E5131A7B3F2BQ26775756-DDD72178-4536-4B19-9ADD-460885E421E8Q26998390-E673C9E3-939E-44AA-A90B-AFBC155A4FEDQ28394117-BB1CE384-B641-4728-9D4C-95C6471082B9Q33527462-0EDC3DEF-840A-4441-9D3E-254C6E32CCF6Q33653385-B74C219F-EC92-4D1B-802D-EF616A62B46BQ33744245-1FB479C7-4E64-4485-9236-A2BE5603613AQ33782338-DCFC3A43-F908-4504-A19B-2B0513C67FCEQ34457056-59D9EA46-4489-474A-9142-0084DDA288D8Q34655526-5810C210-A93A-40F4-857E-9547F3E35C75Q34704902-1B25B376-43CF-4327-9F25-EE4B1FB2EE6BQ34781487-705D8364-52E9-4743-9BF8-B422030E2D3CQ35418333-514CBAE6-8EAA-473D-9291-43340201AB08Q35617573-7E4083CC-5E69-4BDC-9EB1-A28DFDEA89ABQ35724900-3D958B17-59E2-4645-853E-2846427FE429Q35790589-39B3DEE8-8F2F-4A7D-9E3D-0E8C4683FE01Q35829864-879E1CD2-5600-460F-83B1-3B5D31A1B56CQ36059553-7226D700-631F-400C-B911-573B50D6B934Q36340132-4AE4635F-8D08-4E97-BEA2-AD08F3F83C74Q36417899-EA9056BA-0F30-413E-9508-5D04DBB0AE98Q36417912-F9FA1426-66A5-44F3-8425-3B822DEE917DQ36437829-3E721AC9-254B-4456-A39E-50FCE2710292Q36659210-0E9118B9-11C8-4463-ABB6-42578598BAC8Q37221965-91153BCE-8A9C-48D6-A14C-1B481220D106Q37233020-9FFDF743-0BCC-4F46-B10F-98B43BC69BEFQ37453484-6073128A-BF59-4884-AC0B-3BD6E2CDEB24Q37751877-F2EF1CF7-CF18-46A0-8AE2-30A743E904FAQ38021183-7F2102F4-0B06-4951-A581-7B4F3DB76BE9Q38023852-6525ECCB-FD1F-45E2-AF5D-0FE6E9587911Q39719559-6CFF0D4D-FF5A-49BF-BB17-E50087B35C54Q41832879-DCA84CF7-2883-43D2-9623-060ACBCD5F6DQ47114844-C120C594-1FF1-40E5-AB40-CD40B9028970Q47852620-3510340E-38B9-4079-B9DD-CD8E1B3FB704Q50102855-918F6F57-8418-455E-AFB7-7D83758E832B
P2860
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@ast
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@en
type
label
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@ast
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@en
prefLabel
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@ast
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@en
P2093
P2860
P1476
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
@en
P2093
P2860
P304
P407
P577
1994-05-01T00:00:00Z